Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Report
including, without limitation, statements in this section regarding our
financial position, business strategy and the plans and objectives of management
for future operations, are forward-looking statements. When used in this Report,
words such as "anticipate," "believe," "estimate," "expect," "intend" and
similar expressions, as they relate to us or our management, identify
forward-looking statements. Such forward-looking statements are based on the
beliefs of management, as well as assumptions made by, and information currently
available to, our management. Actual results could differ materially from those
contemplated by the forward- looking statements as a result of certain factors
detailed in our filings with the SEC. All subsequent written or oral
forward-looking statements attributable to us or persons acting on our behalf
are qualified in their entirety by this paragraph.
The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the financial statements and the
notes thereto contained elsewhere in this Report.
Recent Developments
On November 21, 2022, the Company, NEXT and Merger Sub entered into the NEXT
Merger Agreement pursuant to which (i) Merger Sub will be merged with and into
NEXT, and NEXT will become a wholly-owned subsidiary of the Company, which will
change its name to "NXTCLEAN Fuels Inc.," or such other name as mutually agreed
to by the Company and NEXT; and (ii) each stockholder of NEXT will receive
newly-issued Company securities, including, as applicable, shares of Class A
common stock and/or options or warrants pursuant to which Class A common stock
will be issued. Prior to, and contingent upon, the closing of the NEXT Business
Combination, the Company is to effect a recapitalization pursuant to which all
convertible debt shall be converted into common stock.
On March 1, 2023, NEXT announced Lisa A. Holmes, MSHR, has been appointed to the
board of directors.
For a full description of the NEXT Merger Agreement and the proposed NEXT
Business Combination, please see "Item 1. Business."
On March 22, 2023, we filed with the SEC a proxy statement on Schedule 14A in
connection with a proposal to amend our amended and restated certificate of
incorporation to extend the date by which we must complete an initial business
combination from April 14, 2023 to December 14, 2023, or such earlier date as
determined by the Company's board of directors. If the Extension Amendment
Proposal is approved and the board of directors decides to implement the
Extension, the sponsor or its designees have agreed to contribute to us loans
equal to the lesser of (x) $35,000 or (y) $0.035 for each public share that is
not redeemed for each calendar month (commencing on April 15, 2023 and ending on
the 14th day of each subsequent month), or portion thereof, that is needed by
the Company to complete the business combination until December 14, 2023. Our
shareholders will vote on the Extension Amendment Proposal at the special
meeting of stockholder scheduled to be held on April 10, 2023. In connection
with the Extension Amendment Proposal, holders of our public shares are entitled
to redeem their public shares at a per-share price, payable in cash, equal to
the aggregate amount then on deposit in the trust account, including interest
(which interest shall be net of taxes payable), divided by the number of then
outstanding public shares. For more information, please see our proxy statement
on Schedule 14A filed with the SEC on March 22, 2023.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date.
Our only activities from January 4, 2021 (inception) through December 31, 2022
were organizational activities, those necessary to prepare for our initial
public offering, and identifying a target company for a business combination. We
do not expect to generate any operating revenues until after the completion of
our business combination. We generate non-operating income in the form of
interest income on marketable securities held in the trust account. We incur
expenses as a result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence expenses.
For the year ended December 31, 2022, we had a net income of $4,892,914, which
consists of interest income on marketable securities held in the trust account
and bank account of $2,539,764 and change in fair value of warrant liability of
$4,420,646, offset by operating costs of $1,548,829 and offering costs allocated
to warrants at the IPO date of $27,670.
For the period from January 4, 2021 (inception) through December 31, 2021, we
had net loss of $3,758, which consisted of formation and operating costs of
$3,768, partially offset by bank interest income of $10.
Liquidity, Going Concern and Capital Resources
On January 14, 2022, we consummated our initial public offering of 17,250,000
units, at $10.00 per unit, generating gross proceeds of $172,500,000.
Simultaneously with the closing of the IPO, we completed the private placement
of an aggregate of 8,037,500 private placement warrants at a price of $1.00 per
private placement warrant, generating gross proceeds of $8,037,500.
Following the IPO, the full exercise of the over-allotment option, and the sale
of the private placement warrants, a total of $175,950,000 was placed in the
trust account. We incurred $10,799,030 in IPO-related costs, including
$3,450,000 of underwriting commissions, $6,900,000 of deferred underwriting
commissions, and $449,030 of other offering costs, partially offset by the
reimbursement of $1,035,000 of offering expenses by the underwriters.
For the year ended December 31, 2022, cash used in operating activities was
$1,378,921. Net income of $4,892,914 was affected by interest earned on
marketable securities held in the trust account of $2,537,410, financing costs
of warrant issuance of $27,670, deferred tax benefit of $119,625 and change in
fair value of the warrant liability of $4,420,646. Changes in operating assets
and liabilities provided $538,926 in cash for operating activities.
For the period from January 4, 2021 (inception) through December 31, 2021, cash
used in operating activities was $2,121.
As of December 31, 2022, we had marketable securities held in the trust account
of $178,487,410 (including approximately $2,537,410 of interest income)
consisting of securities held in a money market fund with a maturity of 180 days
or less. Interest income on the balance in the trust account may be used by us
to pay taxes. Through December 31, 2022, we have not withdrawn any interest
earned from the trust account.
31
We intend to use substantially all of the funds held in the trust account,
including any amounts representing interest earned on the trust account (less
income taxes payable), to complete our business combination. To the extent that
our capital stock or debt is used, in whole or in part, as consideration to
complete our business combination, the remaining proceeds held in the trust
account will be used as working capital to finance the operations of the target
business or businesses, make other acquisitions and pursue our growth
strategies.
As of December 31, 2022, we had cash of $451,473. We intend to use the funds
held outside the trust account primarily to identify and evaluate target
businesses, perform business due diligence on prospective target businesses,
travel to and from the offices, plants or similar locations of prospective
target businesses or their representatives or owners, review corporate documents
and material agreements of prospective target businesses, and structure,
negotiate and complete a business combination.
In order to fund working capital deficiencies or finance transaction costs in
connection with a business combination, the sponsor, or certain of our officers
and directors or their affiliates may, but are not obligated to, loan us funds
as may be required. If we complete a business combination, we would repay such
loaned amounts. In the event that a business combination does not close, we may
use a portion of the working capital held outside the trust account to repay
such loaned amounts but no proceeds from our trust account would be used for
such repayment. Up to $1,500,000 of such Working Capital Loans may be
convertible into private placement-equivalent warrants at a price of $1.00 per
warrant at the option of the lender. The warrants would be identical to the
private placement warrants.
In connection with the Company's assessment of going concern considerations in
accordance with Financial Accounting Standard Board's Accounting Standards
Update 2014-15, "Disclosures of Uncertainties about an Entity's Ability to
Continue as a Going Concern," the Company has until April 2023, to consummate a
business combination. It is uncertain that the Company will be able to
consummate a business combination by this time. Additionally, the Company may
not have sufficient liquidity to fund the working capital needs of the Company
until one year from the issuance of these financial statements. If a business
combination is not consummated by this date, there will be a mandatory
liquidation and subsequent dissolution of the Company. Management has determined
that the mandatory liquidation, should a business combination not occur, and
potential subsequent dissolution, raises substantial doubt about the Company's
ability to continue as a going concern. No adjustments have been made to the
carrying amounts of assets or liabilities should the Company be required to
liquidate in April 2023. The Company intends to complete a business combination
before the mandatory liquidation date.
Off-Balance Sheet Financing Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance sheet arrangements as of December 31, 2022. We do not participate in
transactions that create relationships with entities or financial partnerships,
often referred to as variable interest entities, which would have been
established for the purpose of facilitating off-balance sheet arrangements. We
have not entered into any off-balance sheet financing arrangements, established
any special purpose entities, guaranteed any debt or commitments of other
entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease
obligations or long-term liabilities, other than an agreement to pay an
affiliate of the sponsor a total of $10,000 per month for office space,
utilities and secretarial and administrative support. Upon completion of the
initial business combination or liquidation, the Company will cease paying these
monthly fees.
The underwriters are entitled to a deferred underwriting discount of 4.0% of the
gross proceeds of the IPO upon the completion of the Company's initial business
combination.
Critical Accounting Policies
The preparation of financial statements and related disclosures in conformity
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those
estimates. We have identified the following critical accounting policies:
32
Warrant Liability
The Company accounts for private placement warrants for shares of the Company's
common stock that are not indexed to its own shares as liabilities at fair value
on the balance sheet. The private placement warrants are subject to
remeasurement at each balance sheet date and any change in fair value is
recognized as a component of other income (expense), net on the statement of
operations. The Company will continue to adjust the liability for changes in
fair value until the earlier of the exercise or expiration of the warrants. At
that time, the portion of the warrant liability related to the warrants will be
reclassified to additional paid-in capital.
Class A Common Stock Subject to Possible Redemption
The Company's Class A common stock sold as part of the units in the IPO contains
a redemption feature which allows for the redemption of such public shares in
connection with the Company's liquidation, or if there is a stockholder vote or
tender offer in connection with the Company's initial business combination. In
accordance with ASC 480-10-S99, the Company classifies such public shares
subject to redemption outside of permanent equity as the redemption provisions
are not solely within the control of the Company. The public shares sold as part
of the units in the IPO will be issued with other freestanding instruments
(i.e., public warrants) and as such, the initial carrying value of public shares
classified as temporary equity will be the allocated proceeds determined in
accordance with ASC 470-20. The public shares are subject to ASC 480-10-S99 and
are currently not redeemable as the redemption is contingent upon the occurrence
of events mentioned above. According to ASC 480-10-S99-15, no subsequent
adjustment is needed if it is not probable that the instrument will become
redeemable.
Net Income (Loss) Per Share of Common Stock
Net income (loss) per share of common stock is computed by dividing net income
(loss) by the weighted average number of shares of common stock outstanding for
the period. Remeasurement adjustment associated with the redeemable shares of
Class A common stock is excluded from income (loss) per share of common stock as
the redemption value approximates fair value.
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board ("FASB") issued
Accounting Standards Update ("ASU") 2020-06- "Contracts in Entity's Own Equity
(Subtopic 815-40) ("ASU 2020-06")", to simplify accounting for certain financial
instruments. ASU 2020-06 eliminates the current models that require separation
of beneficial conversion and cash conversion features from convertible
instruments and simplifies the derivative scope exception guidance pertaining to
equity classification of contracts in an entity's own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding
instruments that are indexed to and settled in an entity's own equity. ASU
2020-06 amends the diluted earnings per share guidance, including the
requirement to use the if-converted method for all convertible instruments. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023,
including interim periods within those fiscal years, with early adoption
permitted. The Company is currently assessing the impact, if any, that ASU
2020-06 would have on its financial position, results of operations or cash
flows.
Management does not believe that any other recently issued, but not yet
effective, accounting standards, if currently adopted, would have a material
effect on our financial statements.
Factors That May Adversely Affect our Results of Operations
Our results of operations and our ability to complete an initial business
combination may be adversely affected by various factors that could cause
economic uncertainty and volatility in the financial markets, many of which are
beyond our control. Our business could be impacted by, among other things,
downturns in the financial markets or in economic conditions, increases in oil
prices, inflation, increases in interest rates, supply chain disruptions,
declines in consumer confidence and spending, the ongoing effects of the
COVID-19 pandemic, including resurgences and the emergence of new variants, and
geopolitical instability, such as the military conflict in Ukraine. We cannot at
this time fully predict the likelihood of one or more of the above events, their
duration or magnitude or the extent to which they may negatively impact our
business and our ability to complete an initial business combination.
33
© Edgar Online, source Glimpses